Tarsons Products DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.63×	0.65×	0.66×	0.70×	—
	1.12×	1.02×	0.93×	1.02×	—
	3.5%	5.1%	12.3%	20.0%	—
	0.37×	0.37×	0.38×	0.35×	—
	1.87×	1.87×	1.71×	1.59×	1.27×
	1.7%	2.3%	4.9%	8.0%	—
	2.3%	2.3%	4.8%	7.2%	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TARSONS₹303.95

Tarsons Products Limited

· Pharma & Health

₹ CrorePeersFISCHER LAXMIDENTL FABTECH GKBMcap ₹1,617 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	—	0.70	0.66	0.65	0.63
Interest Burden (Pretax/EBIT) ×	—	1.02	0.93	1.02	1.12
EBIT Margin %	—	20.04	12.29	5.06	3.53
Asset Turnover ×	—	0.35	0.38	0.37	0.37
Financial Leverage (Assets/Equity) ×	1.27	1.59	1.71	1.87	1.87
ROE (5-step product, year-end total equity) %	—	7.99	4.94	2.34	1.74
ROE (owners' profit / average owners' equity) %	—	7.21	4.79	2.26	2.26

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.